New registry monitors liver transplant device in thousands of patients
NCT ID NCT07578441
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is a registry that collects information from up to 5,000 people who received a liver transplant after the donated liver was treated with the VitaSmart HOPE system. The device keeps the liver cool and oxygenated before transplant. The goal is to see how well the device works in everyday hospital use and whether patients and their new livers are doing well up to 5 years after surgery. No extra treatments or visits are required beyond standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE LIVER DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic
Cleveland, Ohio, 44195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A machine that keeps donor livers alive outside the body — could it transform transplantation?
- Frailty test could predict who survives liver transplant waiting list
- Could a single infusion of 'Trainer' cells free liver transplant patients from lifelong drugs?
- Warm liver transplants: could ditching the ice bath reduce organ damage?
- Physiotherapy after liver transplant may boost long-term physical and mental function
- Neck artery scan may foretell danger during liver transplants